Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 32, 2008, Pages 11264-11269

  Shlien, Adam ^a   Tabori, Uri ^a   Marshall, Christian R ^a,b   Pienkowska, Malgorzata ^a   Feuk, Lars ^a,b   Novokmet, Ana ^a   Nanda, Sonia ^a   Druker, Harriet ^a   Scherer, Stephen W ^a,b   Malkin, David ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cancer genetics; Genomic instability; Microarray; p53

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; FAMILIAL CANCER; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GROWTH;

CHROMOSOME ABERRATIONS; COHORT STUDIES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49649110984     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0802970105     Document Type: Article

References (33)

1. Malkin D (2004) Predictive genetic testing for childhood cancer: Taking the road less traveled by. J Pediatr Hematol Oncol 26:546-548.
2. Malkin D, et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
3. Redon R, et al. (2006) Global variation in copy number in the human genome. Nature 444:444-454.
4. Perry GH, et al. (2006) Hotspots for copy number variation in chimpanzees and humans. Proc Natl Acad Sci USA 103:8006-8011.
5. Lupski JR (2007) Genomic rearrangements and sporadic disease. Nat Genet 39:S43-S47.
6. Inoue K, Lupski JR (2002) Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 3:199-242.
7. Vasudevan SA, Nuchtern JG, Shohet JM (2005) Gene profiling of high risk neuroblastoma. World J Surg 29:317-324.
8. Mullighan CG, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764.
9. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898.
10. Camp NJ, et al. (2007) Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 16:1271-1278.
11. Easton DF, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093.
12. Gudmundsson J, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637.
13. Hunter DJ, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874.
14. Stacey SN, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39:865-869.
15. Pinto D, Marshall C, Feuk L, Scherer SW (2007) Copy-number variation in control population cohorts. Hum Mol Genet 16(Spec No 2):R168-R173.
16. Lin M, et al. (2004) dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20:1233-1240.
17. Nichols KE, Malkin D, Garber JE, Fraumeni JF, Jr, Li FP (2001) Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 10:83-87.
18. Feuk L, Carson AR, Scherer SW (2006) Structural variation in the human genome. Nat Rev Genet 7:85-97.
19. Tabori U, Nanda S, Druker H, Lees J, Malkin D (2007) Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 67:1415-1418.
20. Bond GL, et al. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119:591-602.
21. Bond GL, Hu W, Levine A (2005) A single nucleotide polymorphism in the MDM2 gene: From a molecular and cellular explanation to clinical effect. Cancer Res 65:5481-5484.
22. Bischoff FZ, et al. (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization. Cancer Res 50:7979-7984.
23. Eyfjord JE, et al. (1995) TP53 abnormalities and genetic instability in breast cancer. Acta Oncol 34:663-667.
24. Georgiades IB, Curtis LJ, Morris RM, Bird CC, Wyllie AH (1999) Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 18:7933-7940.
25. Primdahl H, et al. (2002) Allelic imbalances in human bladder cancer: Genome-wide detection with high-density single-nucleotide polymorphism arrays. J Natl Cancer Inst 94:216-223.
26. Lane DP (1992) Cancer p53, guardian of the genome. Nature 358:15-16.
27. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70.
28. Krawczak M, et al. (2006) PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 9:55-61.
29. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320.
30. Matsuzaki H, et al. (2004) Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 1:109-111.
31. Nannya Y, et al. (2005) A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65:6071-6079.
32. Komura D, et al. (2006) Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res 16:1575-1584.
33. Higgins ME, Claremont M, Major JE, Sander C, Lash AE (2007) CancerGenes: A gene selection resource for cancer genome projects. Nucleic Acids Res 35:D721-D726.